{
    "clinical_study": {
        "@rank": "63749", 
        "arm_group": {
            "arm_group_label": "Single oral dose group", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This single-center, randomized, double-blind, placebo-controlled, single dose study will\n      investigate the safety, pharmacokinetics, pharmacodynamics of RO6799477 in healthy\n      volunteers."
        }, 
        "brief_title": "A Study of RO6799477 in Healthy Volunteers", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy Volunteer", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male healthy volunteers, aged 18-45 years, inclusive\n\n          -  Male volunteers with female partner of childbearing potential must agree to use an\n             effective form of birth control during the study and for 3 months after\n             discontinuation of treatment.\n\n          -  Body Mass index (BMI) of 18-30 kg/m2, inclusive\n\n        Exclusion Criteria:\n\n          -  Infection with human immunodeficiency virus antibody (HIV 1 and 2), Hepatitis B,\n             hepatitis C\n\n          -  Positive testing for drugs of abuse\n\n          -  Any history of alcohol and/or drug of abuse addiction"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "27", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01893437", 
            "org_study_id": "BP28751", 
            "secondary_id": "2013-000402-28"
        }, 
        "intervention": {
            "arm_group_label": "Single oral dose group", 
            "description": "Single doses of RO6799477", 
            "intervention_name": "RO6799477", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 5, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Leiden", 
                    "country": "Netherlands", 
                    "zip": "2333"
                }
            }
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Single-center, Randomized, Double-blind, Placebo-controlled, Single Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO6799477 Following Oral Administration of Single Ascending Doses in Healthy Volunteers.", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Netherlands: Centrale Commissie Mensgebonden Onderzoek (CCMO)"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Part 1: Safety: Incidence of adverse events", 
            "safety_issue": "No", 
            "time_frame": "18 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01893437"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Part 1 and 2: Pharmacokinetics: plasma concentration of RO6799477", 
            "safety_issue": "No", 
            "time_frame": "Pre-dose, Day 1, 2, 3, 4"
        }, 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}